Cited by 459Cancer, Hypoxia, and MetabolismAmino Acid Enzymes and MetabolismCancer, Lipids, and Metabolism

Glutaminolysis as a target for cancer therapy

Open access
Jin, L, Alesi, G N, Kang, S·2016·Oncogene

Abstract

Cancer cells display an altered metabolic circuitry that is directly regulated by oncogenic mutations and loss of tumor suppressors. Mounting evidence indicates that altered glutamine metabolism in cancer cells has critical roles in supporting macromolecule biosynthesis, regulating signaling pathways, and maintaining redox homeostasis, all of which contribute to cancer cell proliferation and survival. Thus, intervention in these metabolic processes could provide novel approaches to improve cancer treatment. This review summarizes current findings on the role of glutaminolytic enzymes in human cancers and provides an update on the development of small molecule inhibitors to target glutaminolysis for cancer therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2015.447

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • None of the agents targeting glutaminolysis have yet been used clinically.

    “Throughout the discovery of agents targeting glutaminolysis, none have yet been used clinically197.”

    From Glutamine reliance in cell metabolism (2020) · cites this paper as [197]

  • GLS inhibition suppresses proliferation.

    “GLS inhibition suppresses proliferation, and GLS inhibitors are being evaluated in clinical studies for a number of cancers.31,38,39”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jin, L., Alesi, G. N., & Kang, S.
Affiliations
Emory University (US)
Corresponding author
  • Jin, L
  • Kang, S
Venue
Oncogene
Published
2015-11-23
Volume
35
Issue
28
Pages
3619-3625
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2176297535
Cited by
459
References
92
Citations by year
2026: 17 · 2025: 43 · 2024: 46 · 2023: 40 · 2022: 73 · 2021: 62 · 2020: 57 · 2019: 36 · 2018: 44 · 2017: 27 · 2016: 13 · 2015: 1
FWCI
2.76
Type
journal article
Language
en
Open access
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Cancer Society
  • Georgia Cancer Coalition
  • National Institutes of Health
  • National Cancer Institute (R01CA175316, F31CA183365)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
glutaminolysis, glutamine metabolism, cancer metabolism, small molecule inhibitors, cancer therapy, redox homeostasis, macromolecular synthesis, signaling pathways, tumor suppressor, oncogenic mutations
MeSH terms
Antineoplastic Agents, Cell Survival, Glutamine, Humans, Neoplasms, Molecular Structure, Cell Proliferation, Metabolic Networks and Pathways, Small Molecule Libraries, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review